-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
Eli Lilly & Company (LLY) reported fourth quarter 2012 adjusted earnings per share of 85 cents, well above the Zacks ...
-
January 29, 2013
As the first FOMC meeting of 2013 gets underway today, it is perhaps appropriate to acknowledge the Fed's ...
-
January 29, 2013
Pfizer Inc. (PFE) posted fourth quarter earnings of 47 cents per share, 3 cents above the Zacks Consensus Estimate ...
-
January 29, 2013
Tuesday, January 29, 2013 As the first FOMC meeting of 2013 gets underway today, it is perhaps appropriate to ...
-
January 28, 2013
Merck (MRK) recently announced that it has received US Food and Drug Administration (FDA) approval for its ...
-
January 28, 2013
Are LBO's coming back when the broader market is about to hit new all-time highs?
Leveraged buyouts ...
-
January 25, 2013
Novartis (NVS) recently announced that the US Food and Drug Administration (FDA) has approved Exjade (deferasirox) ...
-
January 25, 2013
Celgene Corporation (CELG) recently announced that its oncology drug, Abraxane, has performed well in a phase III ...
-
January 25, 2013
DFC Global Corp. (DLLR) reported operating earnings of 56 cents per share for fiscal second quarter 2013 (ending Dec ...
-
January 25, 2013
IBM's earnings and guidance were a relief for investors.
-
January 25, 2013
The Dow Jones and S&P 500 finished in the green following strong domestic and international economic data coupled ...
-
January 24, 2013
Fuel-gatherer/transporter Tesoro Logistics L.P. (TLLP) raised its fourth quarter 2012 cash distribution to 47.25 ...
-
January 24, 2013
The US Food and Drug Administration (FDA) recently approved Roche's (RHHBY) Avastin (bevacizumab) in combination ...
-
January 24, 2013
The labor market is not doing well and the unemployment rate is hovering around 7.8%. In such a scenario, the ...
-
January 24, 2013
Swiss pharmaceutical giant Novartis (NVS) reported fourth quarter 2012 earnings per share of 84 cents, up 71% from ...
-
January 24, 2013
Perrigo Company (PRGO) recently announced that it has launched over-the-counter (OTC) nicotine polacrilex mini ...
-
January 24, 2013
Bristol-Myers Squibb Company's (BMY) fourth quarter 2012 earnings (excluding special items) of 47 cents per share ...
-
January 23, 2013
In a bid to strengthen its position in the neurology and migraine specialty fields, Allergan, Inc. (AGN) recently ...
-
January 23, 2013
Advanced Micro Devices (AMD) reported a loss of 14 cents per share for the fourth quarter of 2012, better than the ...
